The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced on January 18 that enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollment was stopped because those patients receiving episodic therapy had twice the risk of disease progression (the development of clinical AIDS or death), the major outcome of the study.
Read the full story at http://www.nih.gov/news/pr/jan2006/niaid-18.htm.
Tuesday, January 24, 2006
Tuesday, January 10, 2006
Telecourse: Management of HIV/AIDS
Advances in treatment over the past decade have changed AIDS from a terminal illness to a chronic, long-term medical condition. In this 60-minute telecourse, Dr. Thomas M. Kerkering provides primary care providers with timely, practical information about diagnosing and managing patients with HIV/AIDS. Now available in DVD and VHS formats in the Health Sciences Library.
Subscribe to:
Posts (Atom)
